Contrastes yodados de utilización en Radiología

Thomsen, 2004, Contrast Media Safety Committee of European Society of Urogenital Radiology. Management of acute adverse reactions to contrast media, Eur Radiol, 14, 476, 10.1007/s00330-003-2214-z

Katayama, 1990, Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media, Radiology, 175, 621, 10.1148/radiology.175.3.2343107

Jakobsen, 2007, Physiological effects of contrast media for use in multidetector row computed tomography, Eur J Radiol, 62, S14, 10.1016/j.ejrad.2007.02.021

Stormorken, 1986, Effect of various contrast media on coagulation, fibrinolysis and platelet function, An in vitro and in vivo study Invest Radiol, 21, 348, 10.1097/00004424-198604000-00011

Heinrich, 2009, Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials, Radiology, 250, 68, 10.1148/radiol.2501080833

Jo, 2006, Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial, J Am Coll Cardiol, 48, 924, 10.1016/j.jacc.2006.06.047

Morris, 1982, The effects of media viscosity on hemodynamics in selective arteriography, Invest Radiol, 17, 70, 10.1097/00004424-198201000-00014

Llerena Rojas, 2002, Sustancias de contraste para estudios radiográficos en cardiología intervencionista, Rev Cubana Med, 41, 167

Bellin, 2011, Late adverse reactions to intravascular iodine based contrast media: an update, Eur Radiol, 21, 2305, 10.1007/s00330-011-2200-9

Mehran, 2006, Contrast-induced nephropathy: definition, epidemiology, and patients at risk, Kidney Int Suppl, 100, S11, 10.1038/sj.ki.5000368

Thomsen, 2003, Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines, Br J Radiol, 76, 513, 10.1259/bjr/26964464

Elicker, 2006, IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy, AJR Am J Roentgenol, 186, 1651, 10.2214/AJR.05.0407

Mathew, 2006, Acute renal failure induced by contrast medium: steps towards prevention, BMJ, 333, 539, 10.1136/bmj.38943.401852.80

Gleeson, 2004, Contrast-induced nephropathy, AJR Am J Roentgenol, 183, 1673, 10.2214/ajr.183.6.01831673

Fernández-Cimadevilla, 2011, Nefropatía inducida por contraste, Med Clin (Barc), 137, 84, 10.1016/j.medcli.2010.04.008

Thomsem, 2009, Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT- a pooled analysis of two randomized trials, Eur Radiol, 19, 891, 10.1007/s00330-008-1206-4

Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006

Mehran, 2004, A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation, J Am Coll Cardiol, 44, 1393

McCarthy, 1992, Multiple myeloma and contrast media, Radiology, 183, 519, 10.1148/radiology.183.2.1561361

Solomon, 2007, Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease, Circulation, 115, 3189, 10.1161/CIRCULATIONAHA.106.671644

Barrett, 2006, Contrast induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol, Invest Radiol, 41, 815, 10.1097/01.rli.0000242807.01818.24

Barrett, 1993, Metaanalysis of the relative nephrotoxicity of high and low-osmolality iodinated contrast media, Radiology, 188, 171, 10.1148/radiology.188.1.8511292

Thomsen, 2004, Gadolinium-based contrast media may be nephrotoxic even at approved doses, Eur Radiol, 14, 1654, 10.1007/s00330-004-2379-0

Stacul, 2011, Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines, Eur Radiol, 21, 2527, 10.1007/s00330-011-2225-0

ESUR Guidelines on contrast media. Version 8.1. European Society of Urogenital Radiology [consultado 22 Dic 2013]. Disponible en: http://www.esur.org/guidelines/.

ACR Commitee on Drugs and Contrast Media. ACR Manual on Contrast Media Version 9. 2013. [consultado 20 Dic 2013].Disponible en: http://www.acr.org/Quality-Safety/Resources/Contrast-Manual.

Brar, 2008, Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial, JAMA, 300, 1038, 10.1001/jama.300.9.1038

Tepel, 2000, Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine, N Engl J Med, 343, 180, 10.1056/NEJM200007203430304

Gonzales, 2007, A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity, BMC Med, 5, 32, 10.1186/1741-7015-5-32

Kelly, 2008, Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy, Ann Intern Med, 148, 284, 10.7326/0003-4819-148-4-200802190-00007

2009, Trials, 10, 38, 10.1186/1745-6215-10-38

ACT: No benefit of N-acetylcysteine to reduce contrast-induced nephropathy. [consultado 15 Feb 2013]. Disponible en: http://www.theheart.org/article/1151175.do.

S Owen F RJ, S Hiremath F S, S Myers F A, S Fraser-Hill FM, S Barrett F B. Consensus Guidelines for the Prevention of Contrast Induced Nephropathy. Canadian Association of Radiologists. 2011. Canada. Disponible en: www.car.ca. [consultado 15 Feb 2013].

Kwok, 2013, Measures used to treat contrast-induced nephropathy: overview of reviews, Br J Radiol, 86, 20120272, 10.1259/bjr.20120272

Toso, 2010, Usefulness of atorvastatin (80mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease, Am J Cardiol, 105, 288, 10.1016/j.amjcard.2009.09.026

Spargias, 2009, Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention, Circulation, 120, 1793, 10.1161/CIRCULATIONAHA.109.863159

Li, 2009, Role of probucol in preventing contrast-induced acute kidney injury after coronary interventional procedure, Am J Cardiol, 103, 512, 10.1016/j.amjcard.2008.10.009

Marenzi, 2003, The prevention of radiocontrast-agent-induced nephropathy by hemofiltration, N Engl J Med, 349, 1333, 10.1056/NEJMoa023204

Cruz, 2006, Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review, Am J Kidney Dis, 48, 361, 10.1053/j.ajkd.2006.05.023

Goergen, 2010, Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin, Radiology, 254, 261, 10.1148/radiol.09090690

Vivas, 2000, Reacciones adversas a los medios de contraste yodados en pacientes tratados con interleuquina-2, Radiología, 42, 393

Bessell-Browne, 2007, CT of pheochromocytoma and paraganglioma: risk of adverse events with IV administration of nonionic contrast material, AJR Am J Roentgenol, 188, 970, 10.2214/AJR.06.0827